Novartis on track to deliver Influenza A (H1N1) vaccine for the US
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Novel agent for treatment of Parkinson's disease - Lu 02-750
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
Novo Nordisk increased operating profit by 30% in the first nine months of 2009
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
-
Sales of modern insulins increased by 28% (24% in local currencies).
Sales of NovoSeven® increased by 15% (11% in local currencies).
Sales of Norditropin® increased by 15% (9% in local currencies).
Sales in North America increased by 29% (17% in local currencies).
Sales in International Operations increased by 18% (16% in local currencies).
AstraZeneca PLC Third Quarter & Nine Months Results 2009
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Abbott completes acquisition acquisition of privately held eye care company Visiogen
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Forest Laboratories, Inc. and Gedeon Richter Announce Results from a Phase IIb Study of Cariprazine
- Details
- Category: Clinical Trials
![Forest Laboratories, Inc. Forest Laboratories, Inc.](http://www.worldpharmanews.com/images/stories/logo/forest.gif)
Pandemrix data in an elderly population
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
More Pharma News ...
- Boehringer Ingelheim Animal Health closes deal to acquire Animal Health Business from Pfizer
- Novartis delivers strong new product momentum and operational performance
- Merck Revenues Increase by 2.7% to € 1.9 Billion
- FDA Determines VYVANSE® was Properly Granted Five-Year Market Exclusivity
- Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement
- Bayer and Onyx Initiate Phase III Trial of Nexavar® in Patients with Non-Responsive Thyroid Cancer
- Bayer and Onyx Initiate Phase III Trial of Nexavar in Patients with Non-Responsive Thyroid Cancer